InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Stephen O'Hara. Director active across 1 company, notably OptiBiotix Health Plc. Aggregated, 2 disclosures have been published. Activity tracked since 23 September 2025. The latest transaction was filed on 22 September 2025 (Purchase). Regulator: RNS (LSE). The full history is openly available.
2 of 2 declarations